Skip to main content
Log in

MR of acquired heart disease: ischemic heart disease

  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Reichek N. Magnetic resonance imaging for assessment of myocardial function. Magn Reson Quart 1991; 7(4): 255–274.

    Google Scholar 

  2. Pennell DJ, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992; 70(1): 34–40.

    Google Scholar 

  3. van Rugge FP, et al. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am College Cardiol 1993; 22(2): 431–439.

    Google Scholar 

  4. Baer FM, et al. Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. Eur Heart J 1994; 15(2): 218–225.

    Google Scholar 

  5. van Rugge FP, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 1994; 90(1): 127–138.

    Google Scholar 

  6. Baer FM, et al. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995; 91(4): 1006–1015.

    Google Scholar 

  7. Baer FM, et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996; 78(4): 415–419.

    Google Scholar 

  8. Zerhouni EA, et al. Human heart: tagging with MR imaging-a method for noninvasive assessment of myocardial motion. Radiology 1988; 169(1): 59–63.

    Google Scholar 

  9. Axel L, Dougherty L. Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. Radiology 1989; 172(2): 349–350.

    Google Scholar 

  10. Croisille P, et al. Differentiation of viable and nonviable myocardium by the use of three-dimensional tagged MRI in 2-day-old reperfused canine infarcts. Circulation 1999; 99(2): 284–291.

    Google Scholar 

  11. Manning W, et al. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am College Cardiol 1991; 18: 959–965.

    Google Scholar 

  12. Wilke N, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997; 204(2): 373–384.

    Google Scholar 

  13. Wilke N, et al. Magnetic resonance first pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging 2000

  14. Keijer JT, et al. Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging. Am Heart J 1995; 130(4): 893–901.

    Google Scholar 

  15. Wilke N, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993; 29(4): 485–497.

    Google Scholar 

  16. Jerosch-Herold M, et al. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998; 25: 73–84.

    Google Scholar 

  17. Gould K, Lipscomb K. Effects of coronary stenosis on coronary flow reserve and resistance. Am J Cardiol 1974; 34: 48–55.

    Google Scholar 

  18. Uren NG, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. New England J Med 1994; 330(25): 1782–1788.

    Google Scholar 

  19. Pereira RS, et al. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996; 36(5): 684–693.

    Google Scholar 

  20. Arheden H, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999; 211(3): 698–708.

    Google Scholar 

  21. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997; 7(1): 102–110.

    Google Scholar 

  22. Rogers WJ Jr, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction [see comments]. Circulation 1999; 99(6): 744–750.

    Google Scholar 

  23. Marchal G, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996; 6(1): 2–8.

    Google Scholar 

  24. Kim RJ, et al. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation 1997; 95(7): 1877–1885.

    Google Scholar 

  25. Yabe T, et al. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy [see comments]. Circulation 1995; 92(1): 15–23.

    Google Scholar 

  26. Straeter-Knowlen IM, et al. 1H NMR spectroscopic imaging of myocardial triglycerides in excised dog hearts subjected to 24 hours of coronary occlusion. Circulation 1996; 93(7): 1464–1470.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stillman, A.E. MR of acquired heart disease: ischemic heart disease. Int J Cardiovasc Imaging 17, 461–465 (2001). https://doi.org/10.1023/A:1020114021586

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020114021586

Keywords

Navigation